Five major pharmaceutical companies currently produce FDA-approved GLP-1 medications for weight loss: Novo Nordisk (semaglutide, tirzepatide), Eli Lilly (tirzepatide, retatrutide), Viking Therapeutics, Structure Therapeutics, and Amgen
Eine Verbesserung des Nchternblutglukose-Wertes (14.3 mg/dl), nicht jedoch von HbA1c, wurde auch von Vidal-Casariego et al
However, in studies examining brain GSH in AD, most studies excluded those with a history of stroke or transient ischemic attack
Hot Picks Today "Sold During the Plunge, Now What?"
News Release: Lilly's oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial
Education Peptide Research The Role of Ipamorelin in Growth Hormone Regulation Studies What Is Ipamorelin